The Vitamin D receptor (VDR) is a crucial nuclear receptor that mediates the biological effects of vitamin D. Ligands that activate VDR, known as VDR agonists, are of immense interest in therapeutic development due to their broad impact on cellular processes, including calcium homeostasis, immune modulation, and cell proliferation. Inecalcitol, a synthetic analog of calcitriol, exemplifies the potential of these compounds, showcasing potent VDR agonist activity with significant antineoplastic effects.

Inecalcitol's efficacy stems from its ability to bind to and activate the VDR, leading to downstream effects that can inhibit cancer cell growth and promote apoptosis. This mechanism makes it a valuable tool in the ongoing research for novel cancer treatments. The precise chemical structure of Inecalcitol (C26H40O3) and its high purity (98%) are essential for reproducible results in scientific studies and reliable performance in manufactured products. Its use as a diagnostic reagent also highlights its specificity and effectiveness in biological assays.

As the pharmaceutical industry continues to explore targeted therapies, the demand for high-quality VDR agonists like Inecalcitol is on the rise. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting this demand by ensuring a consistent and reliable supply of this vital compound. By providing access to Inecalcitol, we support researchers in their efforts to unlock new therapeutic strategies and advance our understanding of VDR-mediated biological pathways.

The continuous research into VDR agonists like Inecalcitol underscores their importance in addressing unmet medical needs. From its role in antineoplastic research to its applications in diagnostics and potentially even in cosmetic formulations, Inecalcitol represents a compound of significant scientific and commercial value. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a partner in this scientific endeavor, facilitating innovation through the provision of premium chemical products.